Excessive calcineurin‐inhibitor exposure and prolonged corticosteroid use have been associated with tumor progression through proangiogenic and mTOR pathway activation, whereas mTOR inhibitors, such as sirolimus and everolimus, exert antiproliferative effects, and may reduce recurrence risk [56, 57]. Here, MTOR is linked to neoplasm.